BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7603510)

  • 1. Clinical features of MELAS and mitochondrial DNA mutations.
    Goto Y
    Muscle Nerve Suppl; 1995; 3():S107-12. PubMed ID: 7603510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.
    Naini AB; Lu J; Kaufmann P; Bernstein RA; Mancuso M; Bonilla E; Hirano M; DiMauro S
    Arch Neurol; 2005 Mar; 62(3):473-6. PubMed ID: 15767514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype.
    Melone MA; Tessa A; Petrini S; Lus G; Sampaolo S; di Fede G; Santorelli FM; Cotrufo R
    Arch Neurol; 2004 Feb; 61(2):269-72. PubMed ID: 14967777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA mutation and muscle pathology in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.
    Mita S; Tokunaga M; Kumamoto T; Uchino M; Nonaka I; Ando M
    Muscle Nerve Suppl; 1995; 3():S113-8. PubMed ID: 7603511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes.
    Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H
    J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.
    James AM; Wei YH; Pang CY; Murphy MP
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):401-7. PubMed ID: 8809026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c oxidase activity is deficient in blood vessels of patients with myoclonus epilepsy with ragged-red fibers.
    Hasegawa H; Matsuoka T; Goto Y; Nonaka I
    Acta Neuropathol; 1993; 85(3):280-4. PubMed ID: 8384773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Tokunaga M; Mita S; Sakuta R; Nonaka I; Araki S
    Ann Neurol; 1993 Mar; 33(3):275-80. PubMed ID: 7684581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases.
    Shanske S; Coku J; Lu J; Ganesh J; Krishna S; Tanji K; Bonilla E; Naini AB; Hirano M; DiMauro S
    Arch Neurol; 2008 Mar; 65(3):368-72. PubMed ID: 18332249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.
    Zeviani M; Muntoni F; Savarese N; Serra G; Tiranti V; Carrara F; Mariotti C; DiDonato S
    Eur J Hum Genet; 1993; 1(1):80-7. PubMed ID: 8069654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS).
    Nishino I; Komatsu M; Kodama S; Horai S; Nonaka I; Goto Y
    Muscle Nerve; 1996 Dec; 19(12):1603-4. PubMed ID: 8941275
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical and molecular genetic study of MELAS and MERRF in Korean patients.
    Kim DS; Jung DS; Park KH; Kim IJ; Kim CM; Lee WH; Rho SK
    J Korean Med Sci; 2002 Feb; 17(1):103-12. PubMed ID: 11850598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.
    Moraes CT; Ciacci F; Silvestri G; Shanske S; Sciacco M; Hirano M; Schon EA; Bonilla E; DiMauro S
    Neuromuscul Disord; 1993 Jan; 3(1):43-50. PubMed ID: 8392410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical MELAS associated with mitochondrial tRNA(Lys) gene A8296G mutation.
    Sakuta R; Honzawa S; Murakami N; Goto Y; Nagai T
    Pediatr Neurol; 2002 Nov; 27(5):397-400. PubMed ID: 12504210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MERRF/MELAS overlap syndrome due to the m.3291T>C mutation.
    Liu K; Zhao H; Ji K; Yan C
    Metab Brain Dis; 2014 Mar; 29(1):139-44. PubMed ID: 24338029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.
    Manfredi G; Schon EA; Moraes CT; Bonilla E; Berry GT; Sladky JT; DiMauro S
    Neuromuscul Disord; 1995 Sep; 5(5):391-8. PubMed ID: 7496173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA.
    Campos Y; Martin MA; Lorenzo G; Aparicio M; Cabello A; Arenas J
    Muscle Nerve; 1996 Feb; 19(2):187-90. PubMed ID: 8559168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of the COII/tRNA(Lys) intergenic 9-bp deletion in mitochondrial DNA of Taiwanese patients with MELAS or MERRF syndrome.
    Liu CS; Cheng WL; Chen YY; Ma YS; Pang CY; Wei YH
    Ann N Y Acad Sci; 2005 May; 1042():82-7. PubMed ID: 15965049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strongly succinate dehydrogenase-reactive blood vessels (SSV) in various neuromuscular diseases].
    Matsuoka T; Hasegawa H; Nonaka I
    Rinsho Shinkeigaku; 1992 Jun; 32(6):645-7. PubMed ID: 1424348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.
    Betts J; Jaros E; Perry RH; Schaefer AM; Taylor RW; Abdel-All Z; Lightowlers RN; Turnbull DM
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):359-73. PubMed ID: 16866982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.